Literature DB >> 19573017

Dimerization of tyrosine phosphatase PTPRO decreases its activity and ability to inactivate TrkC.

Amy E Hower1, Pedro J Beltran, John L Bixby.   

Abstract

Receptor-protein tyrosine phosphatases (RPTPs), like receptor tyrosine kinases, regulate neuronal differentiation. While receptor tyrosine kinases are dimerized and activated by extracellular ligands, the extent to which RPTPs dimerize, and the effects of dimerization on phosphatase activity, are poorly understood. We have examined a neuronal type III RPTP, PTPRO; we find that PTPRO can form dimers in living cells, and that disulfide linkages in PTPROs intracellular domain likely regulate dimerization. Dimerization of PTPROs transmembrane and intracellular domains, achieved by ligand binding to a chimeric fusion protein, decreases activity toward artificial peptides and toward a putative substrate, tropomyosin-related kinase C (TrkC). Dephosphorylation of TrkC by PTPRO may be physiologically relevant, as it is efficient, and TrkC and PTPRO can be co-precipitated from transfected cells. Inhibition of PTPROs phosphatase activity by dimerization is interesting, as dimerization of a related RPTP, CD148/PTPRJ, increases activity. Thus, our results suggest a complex relationship between dimerization and activity in type III RPTPs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19573017     DOI: 10.1111/j.1471-4159.2009.06261.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase.

Authors:  Keiko Takahashi; Raymond L Mernaugh; David B Friedman; Rebecca Weller; Nobuo Tsuboi; Hironobu Yamashita; Vito Quaranta; Takamune Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 2.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

Review 3.  Inside the human cancer tyrosine phosphatome.

Authors:  Sofi G Julien; Nadia Dubé; Serge Hardy; Michel L Tremblay
Journal:  Nat Rev Cancer       Date:  2011-01       Impact factor: 60.716

Review 4.  Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack.

Authors:  Alma N Mohebiany; Roman M Nikolaienko; Samuel Bouyain; Sheila Harroch
Journal:  FEBS J       Date:  2012-07-05       Impact factor: 5.542

5.  Interactions between a receptor tyrosine phosphatase and a cell surface ligand regulate axon guidance and glial-neuronal communication.

Authors:  Hyung-Kook Peter Lee; Amy Cording; Jost Vielmetter; Kai Zinn
Journal:  Neuron       Date:  2013-06-05       Impact factor: 17.173

Review 6.  R3 receptor tyrosine phosphatases: conserved regulators of receptor tyrosine kinase signaling and tubular organ development.

Authors:  Mili Jeon; Kai Zinn
Journal:  Semin Cell Dev Biol       Date:  2014-09-19       Impact factor: 7.727

7.  Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity.

Authors:  Fauzia Chaudhary; Robert Lucito; Nicholas K Tonks
Journal:  Biochem J       Date:  2015-01-01       Impact factor: 3.857

8.  Protein tyrosine phosphatase receptor type O regulates development and function of the sensory nervous system.

Authors:  Manuel R Gonzalez-Brito; John L Bixby
Journal:  Mol Cell Neurosci       Date:  2009-09-30       Impact factor: 4.314

9.  Protein tyrosine phosphatase receptor type O inhibits trigeminal axon growth and branching by repressing TrkB and Ret signaling.

Authors:  Graziana Gatto; Irina Dudanova; Philipp Suetterlin; Alun M Davies; Uwe Drescher; John L Bixby; Rüdiger Klein
Journal:  J Neurosci       Date:  2013-03-20       Impact factor: 6.167

10.  Interactions between Type III receptor tyrosine phosphatases and growth factor receptor tyrosine kinases regulate tracheal tube formation in Drosophila.

Authors:  Mili Jeon; Matthew P Scott; Kai Zinn
Journal:  Biol Open       Date:  2012-04-24       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.